Submission Details
| 510(k) Number | K003687 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 30, 2000 |
| Decision Date | December 22, 2000 |
| Days to Decision | 22 days |
| Submission Type | Special |
| Review Panel | Toxicology (TX) |
| Summary | Statement |
K003687 is an FDA 510(k) clearance for the VERDICT II THC/COC/OPI/AMP, VERDICTII THC/COC/OPI,VERDICT II THC/COC/AMP,VERDICT II THC/COC/PCP,VERDICT II THC/COC, a Reagents, Test, Tetrahydrocannabinol (Class II — Special Controls, product code DKE), submitted by Medtox Diagnostics, Inc. (Burlington, US). The FDA issued a Cleared decision on December 22, 2000, 22 days after receiving the submission on November 30, 2000. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3870.
| 510(k) Number | K003687 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 30, 2000 |
| Decision Date | December 22, 2000 |
| Days to Decision | 22 days |
| Submission Type | Special |
| Review Panel | Toxicology (TX) |
| Summary | Statement |
| Product Code | DKE — Reagents, Test, Tetrahydrocannabinol |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3870 |